These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 5165540)

  • 41. Neuropharmacological studies of effect of new central depressant, 8-chloro-6-phenyl-4H-s-triazolo (4,3-a) (1,4) benzodiazepine (D-40TA) on EEG and central sympathetic activating mechanism in cats.
    Fukuda N; Saji Y; Nagawa Y
    Jpn J Pharmacol; 1974 Feb; 24(1):75-88. PubMed ID: 4545935
    [No Abstract]   [Full Text] [Related]  

  • 42. Pharmacological studies on 1-methyl-7-nitro-5-phenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one (S-1530).
    Sakai S; Kitagawa S; Yamamoto H
    Arzneimittelforschung; 1972 Mar; 22(3):534-9. PubMed ID: 5067925
    [No Abstract]   [Full Text] [Related]  

  • 43. Central actions of some beta-adrenoceptor blocking agents.
    Shah UH; Jindal MN; Patel VK; Kelkar VV
    Arzneimittelforschung; 1974 Oct; 24(10):1581-4. PubMed ID: 4154760
    [No Abstract]   [Full Text] [Related]  

  • 44. Synthesis and central nervous system effects of 8.9-dihydro(1)benzazepino(3,2.1-ak)(1,4)benzodiazepin-1(2H)-ones and (1) binzazepino(3,2,1-jk)(1,4)benzodiazepin-1(2H)-ones.
    Toscano L; Seghetti E; Fioriello G
    J Med Chem; 1975 Oct; 18(10):976-81. PubMed ID: 1159692
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Basic tricyclic oxyiminoethers and their pharmacological properties].
    Aichinger G; Behner O; Hoffmeister F; Schütz S
    Arzneimittelforschung; 1969 Jun; 19():Suppl 5a:838+. PubMed ID: 5819763
    [No Abstract]   [Full Text] [Related]  

  • 46. The central action of gamma-butyrolactone and gamma-hydroxybutyrate.
    Ban T; Takaori S; Sasa M; Shimamoto K
    Jpn J Pharmacol; 1967 Mar; 17(1):30-45. PubMed ID: 5299973
    [No Abstract]   [Full Text] [Related]  

  • 47. Neuropharmacological actions of labetalol.
    Dadhich AP; Khanna NK; Vyas DS; Jain P
    Indian J Physiol Pharmacol; 1979; 23(1):39-43. PubMed ID: 437873
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Studies on some aspects of the neuropharmacology of butylurea.
    Dar MS; Fakouhi T
    Arch Int Pharmacodyn Ther; 1974 Apr; 208(2):204-12. PubMed ID: 4854473
    [No Abstract]   [Full Text] [Related]  

  • 49. Effects of some substituted phenanthrenes on the central nervous system.
    Roszkowski AP; Schuler ME; Nelson PH
    J Med Chem; 1972 Dec; 15(12):1336-8. PubMed ID: 4635985
    [No Abstract]   [Full Text] [Related]  

  • 50. New benzothiazines. 4. 1H-2,3-benzothiazin-4(3H)-one 2,2-dioxide and 2H-1,2-benzothiazin-3(4H)-one 1,1-dioxide nitrogen derivatives with central nervous system activity.
    Sianesi E; Redaelli R; Magistretti MJ; Massarani E
    J Med Chem; 1973 Oct; 16(10):1133-7. PubMed ID: 4749470
    [No Abstract]   [Full Text] [Related]  

  • 51. 4'-Fluoro-4-(1,4,5,6-tetrahydroazepinol[4,5-b]indol-3(2H)-yl)butyrophenones.
    Hester JB; Rudzik AD; Keasling HH; Veldkamp W
    J Med Chem; 1970 Jan; 13(1):23-6. PubMed ID: 5460894
    [No Abstract]   [Full Text] [Related]  

  • 52. Synthesis and anticonvulsant activities of some triazolothiadiazole derivatives.
    Deng XQ; Dong ZQ; Song MX; Shu B; Wang SB; Quan ZS
    Arch Pharm (Weinheim); 2012 Jul; 345(7):565-73. PubMed ID: 22532235
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nicotine potentiates sodium pentobarbital but not ethanol induced sleep.
    Modak AT; Alderete BE
    Subst Alcohol Actions Misuse; 1983; 4(4):321-9. PubMed ID: 6670056
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The pharmacology of fletazepam a centrally-acting muscle relaxant.
    Barnett A; Goldstein J; Fiedler EP; Taber RI
    Arch Int Pharmacodyn Ther; 1974 Nov; 212(1):164-74. PubMed ID: 4476200
    [No Abstract]   [Full Text] [Related]  

  • 55. 1-(2-aminoethyl)-6-aryl-4H- [1,2,4]triazolo[4,3-a][1,4]benzodiazepines with diuretic and natriuretic activity.
    Hester JB; Ludens JH; Emmert DE; West BE
    J Med Chem; 1989 Jun; 32(6):1157-63. PubMed ID: 2724291
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pharmacology of diphenylalkyl derivatives. 3. Correlations between the effect and structure of diphenylpropionitrile derivatives.
    Leszkovszky G; Tardos L; Takács K
    Acta Physiol Acad Sci Hung; 1966; 30(3):283-5. PubMed ID: 5989872
    [No Abstract]   [Full Text] [Related]  

  • 57. Neuro-pharmacological studies on SB 5833, a new psychotherapeutic agent of the benzodiazepine class.
    Ferrini R; Miragoli G; Taccardi B
    Arzneimittelforschung; 1974 Dec; 24(12):2029-32. PubMed ID: 4156177
    [No Abstract]   [Full Text] [Related]  

  • 58. Central nervous system agents. 3. Structure-activity relationship of a series of diphenylaminopropanols.
    Keasling HH; Moffett RB
    J Med Chem; 1971 Nov; 14(11):1106-11. PubMed ID: 5115212
    [No Abstract]   [Full Text] [Related]  

  • 59. Certain aspects of pharmacological profiles of chlordiazepoxide and diazepam.
    Jindal MN; Doctor RB; Kelkar VV; Choksey HK
    Indian J Physiol Pharmacol; 1968 Oct; 12(4):141-52. PubMed ID: 5737357
    [No Abstract]   [Full Text] [Related]  

  • 60. A novel class of potential central nervous system agents. 3-Phenyl-2-(1-piperazinyl)-5H-1-benzazepines.
    Hino K; Nagai Y; Uno H; Masuda Y; Oka M; Karasawa T
    J Med Chem; 1988 Jan; 31(1):107-17. PubMed ID: 2891853
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.